Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biopharmaceuticals Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Biopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan ...

June 2018 134 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Checkpoint Inhibitors for Treating Cancer Market 2018, Forecast to 2023

US$ 4,880.00

... Checkpoint Inhibitors for Treating Cancer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 119 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Coverslipper Market 2018, Forecast to 2023

US$ 4,880.00

... of the Report: This report focuses on the Coverslipper in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

June 2018 136 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Disposable Medical Supplies Market 2018, Forecast to 2023

US$ 4,880.00

... on the Disposable Medical Supplies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 147 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Histology Equipment Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Histology Equipment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 135 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hospital Beds Market 2018, Forecast to 2023

US$ 4,880.00

... report focuses on the Hospital Beds in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 154 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hydrocephalus Shunts Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Hydrocephalus Shunts in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 129 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Lancets Market 2018, Forecast to 2023

US$ 4,880.00

... This report focuses on the Lancets in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 146 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Large Volume Wearable Injectors Market 2018, Forecast to 2023

US$ 4,880.00

... the Large Volume Wearable Injectors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... , regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 131 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Liquid Biopsy Products Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Liquid Biopsy Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 132 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pressure Infusor Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Pressure Infusor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, ...

June 2018 146 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pulse Oximeters Market 2018, Forecast to 2023

US$ 4,880.00

... Report: This report focuses on the Pulse Oximeters in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes ...

June 2018 137 pages

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Surgical Mesh Market 2018, Forecast to 2023

US$ 4,880.00

... focuses on the Surgical Mesh in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... increasing demand for Surgical Mesh in the regions of North America, Europe and Asia. Globally, the Surgical Mesh industry market is concentrated as the ...

June 2018 133 pages

Global Disposable Medical Supplies Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 3,480.00

... display the global Disposable Medical Supplies market. Chapter 1, to describe Disposable Medical Supplies Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Disposable Medical Supplies, with ...

June 2018 146 pages

Global Conjunctivitis Drugs Market 2018-2024

US$ 2,750.00

... of antibiotic of a single drug is improved. Market Analysis: The “Global Bacterial Conjunctivitis Drugs Market” is estimated to witness a CAGR of 2.1% during the forecast period 2018–2024. The bacterial conjunctivitis drugs market is analyzed based on two ...

June 2018 82 pages

2018 World Animal Health Market: Strategic Assessments of Leading Suppliers

US$ 4,850.00

This report provides a worldwide strategic overview of the animal health market, including: Five-year forecasts for: Major market segments Key geographic regions Assessment of major ...

June 2018 83 pages

Rhino-Conjunctivitis - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Rhino-Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Rhino-Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

June 2018 76 pages

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H1 2018

US$ 3,500.00

... this report also reviews key players involved in Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) targeted therapeutics development with respective active and ...

June 2018 70 pages

A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H1 2018

US$ 3,500.00

... molecule type. It also reviews key players involved in A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) targeted therapeutics development with respective active and dormant ...

June 2018 55 pages

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2018

US$ 3,500.00

... Alpha L-Iduronidase (IDUA or EC 3.2.1.76) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 52 pages

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H1 2018

US$ 3,500.00

... Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 53 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) - Pipeline Review, H1 2018

US$ 2,000.00

... Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

June 2018 31 pages

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2018

US$ 3,500.00

... N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 48 pages

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018

US$ 3,500.00

... Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 123 pages

Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H1 2018

US$ 3,500.00

... Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 50 pages

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018

US$ 3,500.00

... Cell Division Protein FtsZ (ftsz) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 36 pages

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H1 2018

US$ 3,500.00

... Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 92 pages

Frataxin Mitochondrial (Friedreich’s Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 40 pages

Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) development landscape Develop and ...

June 2018 77 pages

Integrin Alpha 7 (ITGA7) - Pipeline Review, H1 2018

US$ 3,500.00

... Integrin Alpha 7 (ITGA7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 26 pages

Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) development landscape Develop and design ...

June 2018 95 pages

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 2018

US$ 3,500.00

... Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 46 pages

Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Review, H1 2018

US$ 3,500.00

... Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 118 pages

Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 2.7.11.1) development landscape Develop and ...

June 2018 44 pages

Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H1 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) development landscape Develop ...

June 2018 39 pages

Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H1 2018

US$ 3,500.00

... type. It also reviews key players involved in Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) targeted therapeutics development with respective active and ...

June 2018 44 pages

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 61 pages

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H1 2018

US$ 3,500.00

... 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 50 pages

Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Pipeline Review, H1 2018

US$ 3,500.00

... Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 41 pages

Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Pipeline Review, H1 2018

US$ 3,500.00

... Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 59 pages

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) - Pipeline Review, H1 2018

US$ 3,500.00

... Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 37 pages

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) development landscape Develop and design ...

June 2018 183 pages

Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 1 (GPRC1A or MGLUR1 or GRM1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 35 pages

Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 7 (GPRC1G or MGLUR7 or GRM7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 43 pages

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Pipeline Review, H1 2018

US$ 3,500.00

... Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 63 pages

Muscarinic Acetylcholine Receptor M4 (CHRM4) - Pipeline Review, H1 2018

US$ 3,500.00

... Muscarinic Acetylcholine Receptor M4 (CHRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 67 pages

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Pipeline Review, H1 2018

US$ 3,500.00

... Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 54 pages

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Pipeline Review, H1 2018

US$ 3,500.00

... Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 53 pages

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Pipeline Review, H1 2018

US$ 3,500.00

... Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

June 2018 30 pages

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) development ...

June 2018 67 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1